Monitor for subsequent amendments detailing the scope of data compromised, regulatory notifications, and any litigation or enforcement actions. The breach of proprietary data and patient PHI introduces legal and competitive risks that could crystallize over time.
Price Chart
Executive Summary
Amgen disclosed a material cybersecurity incident involving unauthorized access to cloud environments and exfiltration of proprietary data, patient protected health information, and other data. The company believes the incident is not reasonably likely to have a material financial impact, but the investigation is ongoing and the full scope of data compromised remains unknown.
Key Facts
- Unauthorized activity detected in July 2026 in cloud environments hosted by third-party providers.
- Data exfiltrated includes proprietary data, patient protected health information, and other information.
- No impact identified to products, manufacturing operations, financial reporting systems, or ability to meet patient needs to date.
- Incident determined material on July 29, 2026, based on volume and sensitivity of potentially impacted files.
- Company believes incident is not reasonably likely to have a material impact on financial condition or results of operations.
- Investigation remains ongoing; company will amend the 8-K as information becomes available.
Financial Impact
No specific financial impact quantified; company states it is not reasonably likely to be material. Potential costs from remediation, legal, regulatory, and reputational damage are unquantified.
Risk Factors
- Regulatory penalties and fines from HIPAA or other data privacy authorities.
- Potential class-action lawsuits from affected patients or shareholders.
- Loss of intellectual property or competitive advantage from exfiltrated proprietary data.
- Reputational damage impacting patient and partner trust.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000318154-26-000119 |
| Document: 0000318154-26-000119-index-headers.html | 0000318154-26-000119 |
| Document: 0000318154-26-000119-index.html | 0000318154-26-000119 |
| Document: 0000318154-26-000119.txt | 0000318154-26-000119 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | ANALYST-DOWNGRADE | $382.47 $379.78 | ▲ +0.70% | ▲ +0.20% | $402.88 (−5.34%) |
Sep 8, 2026 24d ago | ANALYST-DOWNGRADE | $393.17 $375.65 | ▲ +4.46% | ▲ +3.34% | $402.88 (−2.47%) |
Aug 14, 2026 7w ago | Court Ruling | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $402.88 (−2.97%) |
Aug 13, 2026 7w ago | Insider Cluster | $415.21 $439.33 | ▲ +5.81% | ▲ +7.18% | $402.88 (−2.97%) |
Aug 11, 2026 7w ago | Court Ruling | $414.30 $425.28 | ▲ +2.65% | ▲ +3.05% | $402.88 (−2.76%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $402.88 (−3.43%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $402.88 (−3.43%) |
Aug 7, 2026 7w ago | Insider Cluster | $417.20 $419.38 | ▲ +0.52% | ▲ +0.57% | $402.88 (−3.43%) |
Aug 4, 2026 8w ago | GOVT-CONTRACT | $390.02 $414.30 | ▲ +6.23% | ▲ +6.33% | $402.88 (+3.30%) |
Jul 31, 2026 8w ago | 8-K | $378.87 $417.20 | ▼ −10.12% | ▼ −8.09% | $402.88 (−6.34%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access